Suzuken Co., Ltd.
Stock Price Chart
2026/11/06 12:54 UpdatedPrice Trend
2026/11/06 12:54 UpdatedPrice & Trading Details
2026/11/06 12:54 UpdatedPRICE
TRADING
Analyst Recommendations 3 analysts
Updated 2026/11/01Earnings Calendar
Updated 2026/11/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2013/08/04 | ¥14.00 | ¥17.40 | +24.3% |
| 2011/05/08 | ¥35.32 | ¥2.69 | -92.4% |
| 2006/08/09 | ¥22.95 | ¥17.14 | -25.3% |
Shareholder Composition
Updated 2026/11/01Top Mutual Funds / ETFs
Updated 2026/11/01Major Holders
Updated 2026/11/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
Columbia Fd.s Varbl Series TRT II-Columbia Varbl PORT. - Overseas Core
|
2.2M | 0.00% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
1.6M | -2.48% | |
|
American Century ETF Trust-Avantis International Small Cap Value ETF
|
1.3M | +0.77% | |
|
John Hancock Investment Trust-Disciplined Value International Fund
|
1.3M | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.1M | -1.23% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
825.1K | +0.30% |
Dividend History 4Years Growth
Updated 2026/11/01| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥85 | +70.0% |
| 2025 | ¥50 | +11.1% |
| 2024 | ¥45 | +18.4% |
| 2023 | ¥38 | +5.6% |
| 2022 | ¥36 | - |
Financial Performance
2026/11/01 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,239,112M | ¥2,314,828M | ¥2,386,493M | ¥2,399,952M |
| Gross Profit | ¥167,332M | ¥179,694M | ¥185,249M | ¥192,231M |
| Operating Income | ¥20,116M | ¥32,605M | ¥34,876M | ¥37,125M |
| Pretax Income | ¥22,535M | ¥30,636M | ¥42,836M | ¥50,328M |
| Net Income | ¥14,393M | ¥20,345M | ¥29,016M | ¥34,496M |
| EPS | ¥163.19 | ¥236.47 | ¥357.88 | ¥454.58 |
| Operating Margin | 0.90% | 1.41% | 1.46% | 1.55% |
| Balance Sheet | ||||
| Total Assets | ¥1,141,717M | ¥1,146,097M | ¥1,228,686M | ¥1,113,831M |
| Total Equity | ¥417,686M | ¥411,208M | ¥416,306M | ¥407,291M |
| Total Liabilities | ¥724,031M | ¥734,889M | ¥812,380M | ¥706,540M |
| Cash | ¥141,377M | ¥109,026M | ¥181,830M | ¥102,655M |
| Interest-bearing Debt | - | - | - | - |
| Equity Ratio | 36.58% | 35.88% | 33.88% | 36.57% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥9,520M | ¥37,270M | ¥87,216M | -¥65,079M |
| Investing CF | ¥1,439M | -¥46,361M | ¥10,350M | ¥20,378M |
| Financing CF | -¥11,599M | -¥26,219M | -¥31,716M | -¥35,483M |
| Free CF | -¥4,772M | ¥19,528M | ¥71,576M | -¥83,726M |
| Efficiency | ||||
| ROE | 3.45% | 4.95% | 6.97% | 8.47% |
| ROA | 1.26% | 1.78% | 2.36% | 3.10% |
Latest IR Information
-
Notice Regarding Status of Treasury Stock Acquisitions
For October 2026, treasury stock acquisitions were 0 shares, total amount 0 yen. Post-split acquisition cap is 8,000,000 shares (5.91%), and cumulative acquisitions this fiscal year are 1,980,000 shares, total amount 51,311,700,000 yen. Acquisition period: 2026/10/1–2026/10/30.
Read more -
Notice Regarding the Impact of the 2026 Kumamoto Earthquake: Resumption of Production at Kumamoto Plant
As an update on disclosures related to the Kumamoto earthquake, Suzuken Co., Ltd. announced that production at the Sanwa Chemical Research Institute Kumamoto Plant is scheduled to resume from October 19. The company states it will prioritize safety inspections and...
Read more -
Notice Regarding Status of Treasury Stock Acquisition
For September, a total of 990,000 ordinary shares were acquired, total amount 5,131,170,000 yen. Acquisition period was September 1, 2026 to September 30, 2026, acquisition methods were ToSTNeT-3 and market purchases.
Read more -
Notice of Changes in Major Shareholders and Primary Beneficial Owners
A change report for a large shareholding was submitted on 2026-09-09, with changes in major shareholders and the primary beneficial owner. The new principal shareholder is Silchester International Investors LLP. Post-change voting rights share is 10.03%; pre-change was 8.80%. No...
Read more -
Announcement on the results of treasury stock acquisition through off-market purchases (ToSTNeT-3)
Treasury stock acquired: 990,000 shares, total amount 5,131,170,000 yen, acquisition date: 2026-09-03. Purpose of acquisition: to execute a flexible capital policy. Upper limit: 4,000,000 shares (upper limit relative to issued shares), acquisition period: from 2026-09-01 to 2027-03-19. Planned post-split upper...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥3,200
Rating Score: 2.25 (Based on 3 analysts)
※1=Strong Buy, 5=Strong Sell
Suzuken Co., Ltd. (SZUKF) Seasonal returns chart - Yahoo Finance - Yahoo Finance Singapore ↗
Company Information
About
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, Specialty Drug Contract Distribution, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplies medical institutions, and insurance pharmacies. The Healthcare Product Development segment offers ethical drugs, diagnostic reagents, and medical devices and materials. The Community Healthcare and Nursing Care Support segment provides a range of pharmacy and nursing care services. The Healthcare Related Services segment offers contract distribution for manufacturers and contract distribution of orphan drugs. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
